Rajan Sharma
Stock Analyst at Goldman Sachs
(0.06)
# 4,509
Out of 5,154 analysts
5
Total ratings
25%
Success rate
-48.35%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $21.87 | -66.85% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $194.22 | -50.06% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $54.51 | -13.78% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $32.97 | +139.61% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $21.87
Upside: -66.85%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $194.22
Upside: -50.06%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $54.51
Upside: -13.78%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $32.97
Upside: +139.61%